Intermediate stage hepatocellular carcinoma: Comparison of the value of inflammation-based scores in predicting progression-free survival of patients receiving transarterial chemoembolization

Liu, Y; Shi, MT; Chen, SG; Wan, WQ; Shen, LJ; Shen, BY; Qi, H; Cao, F; Wu, Y; Huang, T; Chen, GJ; Mo, JQ; Ye, DD; Zhang, YQ; Feng, ZQ; Fan, WJ

Fan, WJ (corresponding author), Sun Yat Sen Univ Canc Ctr, Dept Minimally Invas Intervent Therapy, Guangzhou 510060, Peoples R China.; Fan, WJ (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Peoples R China.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2021; 17 (3): 740

Abstract

Context and Aims: The identification of inflammation-related prognostic heterogeneity in intermediate-stage hepatocellular carcinoma (HCC) can reveal ......

Full Text Link